In early May 2024, the National Department of Health (NDoH) in South Africa faced a significant setback for people with diabetes. The department announced a potential shortage of insulin pen devices, directing health facilities to ration their distribution. This alarming news came after a tender process that failed to meet the demand, leaving many patients in a challenging situation.Novo Nordisk, the main supplier of insulin pens in South Africa, had previously provided over 14 million pens in just three years. However, due to supply issues, insulin manufacturers began offering only vials,…